MedTrace Logo

Mitochondrial Donation: An 18 Month Outcome Study.

NCT04113447 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-07-20

No results posted yet for this study

Summary

The Investigator proposes to record the fetal and postnatal development of children conceived using Mitochondrial Donation (MD) and to perform expert assessment of development at 18 months (corrected for gestational age) using the internationally validated Bayley-III developmental assessment tool.

Conditions

  • Mitochondrial Diseases

Interventions

OTHER

observational

observational

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • Newcastle-upon-Tyne Hospitals NHS Trust

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04113447 on ClinicalTrials.gov